Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 3Diabetes Mellitus, Type 2 3Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Glioblastoma 2Thyroid Nodule 1Renal Insufficiency 1Pancreatic Neoplasms 1Neoplasms, Adipose Tissue 1Multiple Endocrine Neoplasia Type 1 1Lymphoma, Follicular 1Leukemia, Myelomonocytic, Chronic 1Kidney Failure, Chronic 1Insulin Resistance 1Infertility 1Glioma 1Colorectal Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Body Weight 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Exercise 3Metformin 2Megestrol Acetate 2Yoga 1Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination 1Sitagliptin Phosphate 1Resistance Training 1Radiotherapy, Intensity-Modulated 1Professional Autonomy 1Prebiotics 1Nutrition Assessment 1Motivational Interviewing 1Mirtazapine 1Magnetic Resonance Spectroscopy 1Hematologic Tests 1Doxorubicin 1Dietary Supplements 1Diet Therapy 1Diet 1Cyclophosphamide 1Cisplatin 1Caseins 1Caloric Restriction 1Behavior Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Body Weight × Sitagliptin Phosphate × Clear all
NCT02941445 2016-10-21

Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

University Medical Centre Ljubljana

Phase 4 Completed
24 enrolled

Body Weight, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡